Business Deals
Takeda chases global status with $64bn shortcut
Markets frown on drugmaker's wallet-draining gamble for Shire
Welcome to our new website
As well as being able to load content faster than ever before, you'll now find it's much easier to find all the content you need about the Asian business world.
Pharmaceuticals
Business Deals
Takeda's higher buyout offer prompts Shire to extend deadline
Japanese drugmaker now has until May 8 to firm up record $64bn deal
Equities
Reliance Industries, Yes Bank power India shares to near three-month highs
Hindalco, National Aluminium plunge
Opinion
Japanese companies -- the (adopted) son rises
Business families profit from adult adoption and arranged marriage
Equities
India shares edge higher as software exporters advance on weaker rupee
Tata Consultancy's market value hits $100 billion
Business Deals
Want to buy a company? Prices are skyrocketing
Chinese companies becoming less active acquirers amid trade friction
Business Deals
Why Takeda has bet the farm on Shire
Japanese drug powerhouse desperate for foothold in US market
Business Deals
Takeda's $60bn offer for Shire rejected as too low
'More attractive' proposal requested for would-be record acquisition
Companies
Pharma giant Astellas to invest $1.8bn in M&A diversification bid
Japanese company scouts startups for new drugs as old patents set to expire
Business Deals
Malaysia's IHH eyes India expansion with bid for local hospital group
Offer for Fortis Healthcare is higher than rival consortiums
